Jim Waters, vice president of policy and communications for the Bluegrass Institute, opines that, unable to secure the votes to pass the original proposal, which makes cold, allergy and sinus products containing pseudoephedrine controlled substances requiring a prescription for purchase, supporters of Kentucky's Senate Bill 45 are now floating what they label a compromise: exempt gel caps. Waters says this new tactic by logically challenged politicians reveals the same intellectual denseness demonstrated all along in this fight. He says that this will do nothing to curb meth production in Kentucky, and that it could even do less by giving citizens a false sense of security that something effective was being done to stop the meth problem.